Ivapride 5 Tablet contains Ivabradine 5mg, a selective sinus node inhibitor used primarily for the management of chronic stable angina pectoris and heart failure. Ivabradine acts by specifically inhibiting the If current in the sinoatrial node, leading to heart rate reduction without affecting myocardial contractility or intracardiac conduction. This mechanism results in decreased myocardial oxygen demand, thereby alleviating angina symptoms and improving exercise tolerance. Ivapride 5 is indicated for patients with stable angina who remain symptomatic despite optimal beta-blocker therapy or for those who are intolerant to beta-blockers. Additionally, it is prescribed in chronic heart failure patients with a heart rate above 70 beats per minute to reduce the risk of hospitalization due to worsening heart failure. The recommended dosage is typically one tablet twice daily, with adjustments based on clinical response and heart rate monitoring. Ivapride 5 should be used cautiously in patients with bradycardia, hypotension, or conduction abnormalities. Common adverse effects include bradycardia, luminous phenomena (phosphenes), and dizziness. Contraindications include acute decompensated heart failure, severe hypotension, and pacemaker dependency. Ivapride 5 should be prescribed and monitored by healthcare professionals to ensure optimal therapeutic outcomes.